Menu
GWAS Study

Genome-wide association study reveals two new risk loci for bipolar disorder.

Mühleisen TW, Leber M, Schulze TG et al.

24618891 PubMed ID
GWAS Study Type
24025 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MT
Mühleisen TW
LM
Leber M
ST
Schulze TG
SJ
Strohmaier J
DF
Degenhardt F
TJ
Treutlein J
MM
Mattheisen M
FA
Forstner AJ
SJ
Schumacher J
BR
Breuer R
MS
Meier S
HS
Herms S
HP
Hoffmann P
LA
Lacour A
WS
Witt SH
RA
Reif A
MB
Müller-Myhsok B
LS
Lucae S
MW
Maier W
SM
Schwarz M
VH
Vedder H
KJ
Kammerer-Ciernioch J
PA
Pfennig A
BM
Bauer M
HM
Hautzinger M
MS
Moebus S
PL
Priebe L
CP
Czerski PM
HJ
Hauser J
LJ
Lissowska J
SN
Szeszenia-Dabrowska N
BP
Brennan P
MJ
McKay JD
WA
Wright A
MP
Mitchell PB
FJ
Fullerton JM
SP
Schofield PR
MG
Montgomery GW
MS
Medland SE
GS
Gordon SD
MN
Martin NG
KV
Krasnow V
CA
Chuchalin A
BG
Babadjanova G
PG
Pantelejeva G
AL
Abramova LI
TA
Tiganov AS
PA
Polonikov A
KE
Khusnutdinova E
AM
Alda M
GP
Grof P
RG
Rouleau GA
TG
Turecki G
LC
Laprise C
RF
Rivas F
MF
Mayoral F
KM
Kogevinas M
GM
Grigoroiu-Serbanescu M
PP
Propping P
BT
Becker T
RM
Rietschel M
NM
Nöthen MM
CS
Cichon S
Chapter II

Abstract

Summary of the research findings

Bipolar disorder (BD) is a common and highly heritable mental illness and genome-wide association studies (GWAS) have robustly identified the first common genetic variants involved in disease aetiology. The data also provide strong evidence for the presence of multiple additional risk loci, each contributing a relatively small effect to BD susceptibility. Large samples are necessary to detect these risk loci. Here we present results from the largest BD GWAS to date by investigating 2.3 million single-nucleotide polymorphisms (SNPs) in a sample of 24,025 patients and controls. We detect 56 genome-wide significant SNPs in five chromosomal regions including previously reported risk loci ANK3, ODZ4 and TRANK1, as well as the risk locus ADCY2 (5p15.31) and a region between MIR2113 and POU3F2 (6q16.1). ADCY2 is a key enzyme in cAMP signalling and our finding provides new insights into the biological mechanisms involved in the development of BD.

9,747 European ancestry cases, 14,278 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

24025
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Poland, Australia, Russian Federation, Canada, Germany, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.